Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2012; 18(16): 1851-1860
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1851
Published online Apr 28, 2012. doi: 10.3748/wjg.v18.i16.1851
Table 1 Emetogenic potential of chemotherapeutic agents used in stem cell transplantation
| Chemotherapeutic agent | |
| High (90%) emetogenic risk | Carmustine > 250 mg/m2 |
| Cyclophosphamide > 1500 mg/m2 | |
| Moderate (30%-90%) emetogenic risk | Busulfan |
| Cytarabine > 200 mg/m2 | |
| Melphalan | |
| Low (10%-30%) emetogenic risk | Etoposide |
| Minimal (< 10%) emetogenic risk | Fludarabine |
| Rituximab |
- Citation: Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 2012; 18(16): 1851-1860
- URL: https://www.wjgnet.com/1007-9327/full/v18/i16/1851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i16.1851